Meros Equity
Personal Account
Vera Therapeutics
IPO VERA.NASDAQ Past

Vera Therapeutics

Biotechnology company developing innovative biologic therapeutics

Company website
Ticker

VERA.NASDAQ

Market

us

Foundation year

2016

IPO date

5/13/2021

About

Total Funding 

$188.9M

Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential. The company's gene-editing technology can potentially cure patients with sickle cell disease, cystic fibrosis, and other devastating genetic disorders, enabling physicians to improve gene detection and regulation.

Number of employees

11-50

Headquarters

San Francisco, California, United States

Meros Equity

2022 © All rights reserved

You can always come to our office to discuss any questions with our manager

Dubai

Sharjah Media City, Sharjah, UAE

USA

500 Delaware ave,
STE 1 #1960 Wilmington, DE, USA

Czech Republic

Czech Republic, Prague, Bilkova 855/19

The investment opportunities posted on this website's Pre-IPO section are private placements of securities that are not traded on the open market, subject to the ownership period requirements, and intended for investors who do not require liquid investments. Investments in private companies may be considered speculative, involving high risk, including the significant loss of investment risk. Investors must be able to afford to lose all their investments.